COPD

WASHINGTON, D.C. (October 18, 2016)—Dan Starck, chair of CQRC, responds to the GAO Access Report on Competitive Bidding:

"While the CQRC has supported competitive bidding in concept, we remain deeply concerned about the implementation of the competitive bidding program. Today's report shows that fewer beneficiaries are receiving home oxygen therapy in light of competitive bidding."

Agencies Remain Desperate Over Pre-Claim Despite Delayed Rollout

LONDON and AMSTERDAM (September 7, 2016)—Royal Philips announced preliminary results of an independent, multicenter Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV) study carried out by respiratory experts at St Thomas’ Hospital in London. Philips’s work in chronic obstructive pulmonary disease (COPD) started several decades ago when it began providing health care professionals and patients with innovative treatment solutions and services.

SAN DIEGO (September 7, 2016)—ResMed welcomed positive results from a multicenter, randomized controlled trial known as HOT-HMV. The study was presented today during the 2016 European Respiratory Society International Congress in London.

AMSTERDAM (August 29, 2016)—Royal Philips announced its sponsorship of the documentary “COPD: Highly Illogical—Remembering Leonard Nimoy.” The documentary seeks to educate viewers about COPD through Leonard Nimoy’s personal story of courage, while also providing the latest information about treatments for the chronic disease.

WASHINGTON, D.C. (July 6, 2016)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation’s home oxygen therapy providers and manufacturing companies—commended Congressman Tom Price (R-GA), David Loebsack (D-IA), Cathy McMorris-Rogers (R-WA), Peter Welch (D-VT) and their colleagues in the United States House of Representatives, for passing the Patient Access to Durable Medical Equipment (PADME) Act (H.R.

WASHINGTON, D.C. (June 22, 2016)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation’s leading home oxygen therapy provider and manufacturing companies—commended Senators John Thune and Heidi Heitkamp, as well as Senate Finance Committee Chairman Orrin Hatch and Ranking Member Ron Wyden, and their colleagues in the U.S.

WASHINGTON, D.C.

WASHINGTON, D.C. (May 27, 2016)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation’s leading home respiratory therapy providers and manufacturing companies—warned that findings released from the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) signal fundamental flaws in the competitive bidding rate setting process for Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).

WASHINGTON, D.C. (May 18, 2016)—The Council for Quality Respiratory Care (CQRC) today cautioned that data released from the Centers for Medicare & Medicaid Services (CMS) do not fully reflect the true impact of Medicare cuts recently imposed on Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS), including home-based respiratory therapies.

WASHINGTON, D.C.

SAN DIEGO, Calif. (January 11, 2016)—ResMed today announced it has entered into a definitive agreement to acquire Inova Labs Inc., a privately held medical device company specializing in the development and commercialization of innovative oxygen therapy products. Oxygen therapy is the largest non-drug delivery medical device segment for the treatment of COPD.

WASHINGTON, D.C. (November 18, 2015)—In June, CMS announced its intention to make changes to the HCPCS codes for ventilators, including dramatically lowering the payment rate—by 35 percent—for these devices/therapies, starting on January 1, 2016.